User name

Don't have a user name yet?
Register here.


Krka to Make Its Mark on Russia

Ljubljana, 20 September - Milos Kovacic, CEO of pharmaceuticals Krka which is ready to launch a new production plant in Moscow at the end of the month, said that the Russian plant will produce a generic cholesterol drug under the Krka trademark. However, the medicine will have the status of a Russian national drug, Kovacic told an interview for Saturday's Delo.

The rest of this news item is available to subscribers.
The news item consists of 2.187 characters (without spaces) or 449 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2003